接触性荨麻疹诊治进展

doi:10.35541/cjd.20200079

中华皮肤科杂志 ›› 2021, Vol. 54 ›› Issue (12): 1114-1117.doi: 10.35541/cjd.20200079

接触性荨麻疹诊治进展

刘鑫刘念陈宏翔

华中科技大学同济医学院附属协和医院皮肤科，武汉 430022

收稿日期:2020-02-06 修回日期:2020-07-15 发布日期:2021-12-01
通讯作者: 陈宏翔 E-mail:hongxiangchen@hotmail.com

Diagnosis and treatment of contact urticaria

Liu Xin, Liu Nian, Chen Hongxiang

Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

Received:2020-02-06 Revised:2020-07-15 Published:2021-12-01
Contact: Chen Hongxiang E-mail:hongxiangchen@hotmail.com

摘要/Abstract

摘要： 【摘要】接触性荨麻疹属于慢性荨麻疹中的可诱导性荨麻疹，根据病理生理学机制分为免疫性、非免疫性以及机制不明性接触性荨麻疹。致敏原种类繁多，近年来，由化妆品中相关成分及医务工作者职业暴露诱发的接触性荨麻疹相关报道逐渐增多。详细询问病史及体检是诊断接触性荨麻疹的关键，多种皮肤试验可用于辅助诊断。治疗主要以控制症状为主，避免与致敏原接触是防止复发的关键。

关键词: 荨麻疹, 变应原, 职业病, 胶乳过敏症, 接触性荨麻疹, 治疗, 诊断

Abstract: 【Abstract】 Contact urticaria is a kind of chronic inducible urticaria, and can be classified into immunologic contact urticaria, non-immunological contact urticaria and contact urticaria of unknown pathogenesis according to pathophysiological mechanisms. The allergens responsible for contact urticaria are various, and there have been increasing reports on contact urticaria induced by related ingredients in cosmetics and by occupational exposure of healthcare workers in recent years. Detailed medical history and physical examination are the key to the diagnosis of contact urticaria, and a variety of skin tests can assist in the diagnosis. The main aim of treatment is to control symptoms, and avoiding contact with allergens is the key to preventing recurrence.

Key words: Urticaria, Allergens, Occupational diseases, Latex hypersensitivity, Contact urticaria, Treatment, Diagnosis

刘鑫刘念陈宏翔. 接触性荨麻疹诊治进展[J]. 中华皮肤科杂志, 2021,54(12):1114-1117. doi:10.35541/cjd.20200079

Liu Xin, Liu Nian, Chen Hongxiang. Diagnosis and treatment of contact urticaria[J]. Chinese Journal of Dermatology, 2021, 54(12): 1114-1117.doi:10.35541/cjd.20200079

参考文献 39

［1］	Pesonen M, Koskela K, Aalto⁃Korte K. Contact urticaria and protein contact dermatitis in the Finnish Register of Occupational Diseases in a period of 12 years［J］. Contact Dermatitis, 2020,83（1）:1⁃7. doi: 10.1111/cod.13547.
［2］	Carøe TK, Ebbehøj NE, Bonde JP, et al. Occupational hand eczema and/or contact urticaria: factors associated with change of profession or not remaining in the workforce［J］. Contact Dermatitis, 2018,78（1）:55⁃63. doi: 10.1111/cod.12869.
［3］	Aquino M, Mawhirt S, Fonacier L. Review of contact urticaria syndrome—evaluation to treatment［J］. Curr Treat Options Allergy, 2015,2（4）:365⁃380. doi: 10.1007/s40521⁃015⁃0068⁃7.
［4］	Orb Q, Millsop JW, Harris K, et al. Prevalence and interest in the practice of scratch testing for contact urticaria: a survey of the American contact dermatitis society members［J］. Dermatitis, 2014,25（6）:366⁃369. doi: 10.1097/DER.00000000 00000086.
［5］	Süß H, Dölle⁃Bierke S, Geier J, et al. Contact urticaria: frequency, elicitors and cofactors in three cohorts （Information Network of Departments of Dermatology; Network of Anaphylaxis; and Department of Dermatology, University Hospital Erlangen, Germany）［J］. Contact Dermatitis, 2019,81（5）:341⁃353. doi: 10.1111/cod.13331.
［6］	Amaro C, Goossens A. Immunological occupational contact urticaria and contact dermatitis from proteins: a review［J］. Contact Dermatitis, 2008,58（2）:67⁃75. doi: 10.1111/j.1600⁃0536.2007.01267.x.
［7］	Walter A, Seegräber M, Wollenberg A. Food⁃related contact dermatitis, contact urticaria, and atopy patch test with food［J］. Clin Rev Allergy Immunol, 2019,56（1）:19⁃31. doi: 10.1007/s12016⁃018⁃8687⁃y.
［8］	Gomułka K, Panaszek B. Contact urticaria syndrome caused by haptens［J］. Postepy Dermatol Alergol, 2014,31（2）:108⁃112. doi: 10.5114/pdia.2014.40915.
［9］	McFadden J. Immunologic contact urticaria［J］. Immunol Allergy Clin North Am, 2014,34（1）:157⁃167. doi: 10.1016/j.iac.2013.09. 005.
［10］	Wilkinson M, Solman L, Coenraads PJ, et al. Immediate hypersensitivity to p⁃phenylenediamine［J］. Contact Dermatitis, 2019,80（3）:177⁃178. doi: 10.1111/cod.13156.
［11］	Iwata JI, Inomata N, Sato M, et al. Contact dermatitis with concomitant contact urticaria syndrome due to multiple ingredients of oxidative hair dye［J］. Allergol Int, 2019,68（1）:114⁃116. doi: 10.1016/j.alit.2018.05.005.
［12］	Bourrain JL, Amblard P, Béani JC. Contact urticaria photoinduced by benzophenones［J］. Contact Dermatitis, 2003,48（1）:45⁃46. doi: 10.1034/j.1600⁃0536.2003.480108_1.x.
［13］	Haisma MS, Schuttelaar ML. Contact urticaria caused by the ultraviolet absorber octocrylene in sunscreens［J］. Contact Dermatitis, 2017,77（4）:254⁃256. doi: 10.1111/cod.12806.
［14］	Coelho EQ, Wu S, Nunes RS, et al. Contact urticaria following the use of a cosmetic containing caprylyl glycol: a case report［J］. Contact Dermatitis, 2019,81（4）:308⁃309. doi: 10.1111/cod. 13299.
［15］	Sukakul T, Kumpangsin T, Boonchai W. Contact urticaria caused by salicylic acid in a chemical peel solution［J］. Contact Dermatitis, 2020,82（2）:121⁃122. doi: 10.1111/cod.13405.
［16］	Sanz⁃Sánchez T, Núñez Acevedo B, Rubio Flores C, et al. Contact urticaria caused by tocopherol［J］. Contact Dermatitis, 2018,79（6）:395. doi: 10.1111/cod.13099.
［17］	Verhulst L, Goossens A. Cosmetic components causing contact urticaria: a review and update［J］. Contact Dermatitis, 2016,75（6）:333⁃344. doi: 10.1111/cod.12679.
［18］	中国医师协会皮肤科医师分会, 中华医学会皮肤性病学分会, 国家皮肤与免疫疾病临床医学研究中心. 防控冠状病毒感染疾病⁃19医护人员皮肤黏膜屏障防护共识［J］. 中华皮肤科杂志, 2020,53（3）:159⁃164. doi: 10.35541/cjd.20200112.
［19］	Japundžić I, Vodanović M, Lugović⁃Mihić L. An analysis of skin prick tests to latex and patch tests to rubber additives and other causative factors among dental professionals and students with contact dermatoses［J］. Int Arch Allergy Immunol, 2018,177（3）:238⁃244. doi: 10.1159/000490181.
［20］	Vu M, Rajgopal Bala H, Cahill J, et al. Immediate hypersensitivity to chlorhexidine［J］. Australas J Dermatol, 2018,59（1）:55⁃56. doi: 10.1111/ajd.12674.
［21］	Takahagi S, Tanaka A, Iwamoto K, et al. Contact urticaria syndrome with IgE antibody against a cefotiam⁃unique structure, evoked by nonapparent exposure to cefotiam［J］. Clin Exp Dermatol, 2017,42（5）:527⁃531. doi: 10.1111/ced.13126.
［22］	Aquino M, Rosner G. Systemic contact dermatitis［J］. Clin Rev Allergy Immunol, 2019,56（1）:9⁃18. doi: 10.1007/s12016⁃018⁃8686⁃z.
［23］	Raveendran R. Tips and tricks for controlling eczema［J］. Immunol Allergy Clin North Am, 2019,39（4）:521⁃533. doi: 10. 1016/j.iac.2019.07.006.
［24］	Isaac J, Goldminz AM, Scheinman PL. "Pink sign": the importance of short⁃term occlusive testing in suspected cases of contact urticaria［J］. Dermatitis, 2019,30（2）:168⁃169. doi: 10. 1097/DER.0000000000000441.
［25］	von Krogh G, Maibach HI. The contact urticaria syndrome⁃⁃an updated review［J］. J Am Acad Dermatol, 1981,5（3）:328⁃342. doi: 10.1016/s0190⁃9622（81）70099⁃9.
［26］	闫文萍, 牛莉莉, 张英. 过敏原特异性IgE抗体检测对慢性荨麻疹的诊断价值［J］. 实用检验医师杂志, 2019,11（2）:94⁃96. doi: 10.3969/j.issn.1674⁃7151.2019.02.010.
［27］	中华医学会皮肤性病学分会荨麻疹研究中心. 中国荨麻疹诊疗指南（2018版）［J］. 中华皮肤科杂志, 2019,52（1）:1⁃5. doi: 10.3760/cma.j.issn.0412⁃4030.2019.01.001.
［28］	Jungewelter S, Airaksinen L, Pesonen M. Occupational rhinitis, asthma, and contact urticaria from IgE⁃mediated allergy to pork［J］. Am J Ind Med, 2019,62（1）:80⁃84. doi: 10.1002/ajim.22 921.
［29］	Adisesh A, Robinson E, Nicholson PJ, et al. U.K. standards of care for occupational contact dermatitis and occupational contact urticaria［J］. Br J Dermatol, 2013,168（6）:1167⁃1175. doi: 10.1111/bjd.12256.
［30］	Chularojanamontri L, Tuchinda P, Pongparit K, et al. Contact urticaria caused by alcohol: clinical characteristics and cross⁃reactions［J］. Ann Allergy Asthma Immunol, 2016,117（6）:721⁃723.e1. doi: 10.1016/j.anai.2016.09.434.
［31］	Gimenez⁃Arnau A, Maurer M, De La Cuadra J, et al. Immediate contact skin reactions, an update of contact urticaria, contact urticaria syndrome and protein contact dermatitis ⁃⁃ "a never ending story"［J］. Eur J Dermatol, 2010,20（5）:552⁃562. doi: 10.1684/ejd.2010.1049.
［32］	Magerl M, Altrichter S, Borzova E, et al. The definition, diagnostic testing, and management of chronic inducible urticarias ⁃ the EAACI/GA（2） LEN/EDF/UNEV consensus recommendations 2016 update and revision［J］. Allergy, 2016,71（6）:780⁃802. doi: 10.1111/all.12884.
［33］	Nucera E, Mezzacappa S, Buonomo A, et al. Latex immunotherapy: evidence of effectiveness［J］. Postepy Dermatol Alergol, 2018,35（2）:145⁃150. doi: 10.5114/ada.2018.75235.
［34］	Maurer M, Metz M, Brehler R, et al. Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence［J］. J Allergy Clin Immunol, 2018,141（2）:638⁃649. doi: 10.1016/j.jaci.2017.06.032.
［35］	Bernstein JA, Kavati A, Tharp MD, et al. Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ′real⁃world′ evidence［J］. Expert Opin Biol Ther, 2018,18（4）:425⁃448. doi: 10.1080/14712598.2018.1438406.
［36］	徐艳华, 王菁兰, 王怡玮, 等. 33例141次奥马珠单抗治疗后不良反应回顾性研究［J］. 中华临床免疫和变态反应杂志, 2019,13（6）:516⁃519. doi: 10.3969∕j.issn.1673⁃8705.2019.06. 018.
［37］	Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria［J］. Allergy, 2018,73（7）:1393⁃1414. doi: 10.1111/all.13397.
［38］	陈玉迪, 胡艳, 隋海晶, 等. 抗IgE单克隆抗体在变态反应性疾病治疗中的应用［J］. 中华临床免疫和变态反应杂志, 2018,12（3）:302⁃307. doi: 10.3969/j.issn.1673⁃8705.2018.03.008.
［39］	Di Leo E, Calogiuri G, Macchia L, et al. Use of omalizumab in uncontrolled chronic spontaneous urticaria also improved latex⁃induced contact urticaria［J］. J Allergy Clin Immunol Pract, 2019,7（1）:300⁃302. doi: 10.1016/j.jaip.2018.05.005.

[1]	张宁, 李舒, 李敬. 免疫检查点抑制剂和靶向药物辅助治疗可切除黑素瘤疗效的网状Meta分析[J]. 中华皮肤科杂志, 2022, 0(4): 20200767-e20200767.
[2]	李妍李明徐薇李邻峰. 【开放获取】丙酸氟替卡松乳膏单独或联合卡泊三醇软膏治疗轻中度斑块状银屑病的随机自身对照研究[J]. 中华皮肤科杂志, 2022, 55(3): 260-263.
[3]	李锁向睿宇李志量荆可王媛张寒梅冯素英. 盐裂皮肤间接免疫荧光技术在大疱性类天疱疮诊断中的价值评估[J]. 中华皮肤科杂志, 2022, 55(3): 235-237.
[4]	吕玲吕小岩. 皮肌炎伴发恶性肿瘤的研究进展[J]. 中华皮肤科杂志, 2022, 55(3): 276-279.
[5]	李浩, 王俐韩宪伟孙彤苏芳孙晓冬韩莹杨国玲刘晓明王凯波 . 糖尿病患者服用二肽基肽酶Ⅳ抑制剂后发生大疱性类天疱疮32例临床特征分析[J]. 中华皮肤科杂志, 2022, 55(3): 213-218.
[6]	《脓疱型银屑病诊疗中国专家共识（版）》编写委员会专家组. 脓疱型银屑病诊疗中国专家共识（2022版）[J]. 中华皮肤科杂志, 2022, 55(3): 187-195.
[7]	王娟娟陈容季江苏文星魏钰倩赵莹尹兴平苏玉华施辛. 以精神行为异常为首发症状的67例神经梅毒患者回顾性分析[J]. 中华皮肤科杂志, 2022, 55(3): 231-234.
[8]	温广东冒丹丹张原媛窦沅青赵培吴晨雨张建中. 【开放获取】度普利尤单抗治疗泛发性苔藓状淀粉样变1例国内首报[J]. 中华皮肤科杂志, 2022, 0(2): 20210694-e20210694.
[9]	欧敏, 颜韵灵, 郑宝庆, 王晓华. 银屑病与肥胖相关性的研究进展[J]. 中华皮肤科杂志, 2022, 55(2): 181-184.
[10]	李赛, 薛华忠, 张树文, 蒋娟, 齐淑贞, 赵园园, 张津萍, 沙仲, 乐文静, 王碧伟, 赵诗轩, 朱小凤, 苏晓红. 多西环素-莫西沙星序贯疗法治疗生殖支原体尿道炎/宫颈炎的临床观察[J]. 中华皮肤科杂志, 2022, 0(2): 20210631-e20210631.
[11]	焦晓燕, 尹光文, 阴亚坤, 李冬芹. 妊娠期、围生期带状疱疹25例临床分析[J]. 中华皮肤科杂志, 2022, 0(2): 20210384-e20210384.
[12]	王佳绮, 王平, 李刘雨, 樊奇敏, 朱蒙燕, 王燕清, 周鸿宇, 沈宏, 许爱娥. 皮肤色素减退性淋巴增殖性疾病41例临床病理分析[J]. 中华皮肤科杂志, 2022, 55(2): 110-115.
[13]	包诗杰, 程杨, 晏莹, 范昉, 高婷婷, 冯小兰, 郑亮, 雷卫, 黄琴斯, 张伟明, 周小勇. 人免疫球蛋白和重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗中毒性表皮坏死松解症的对比研究[J]. 中华皮肤科杂志, 2022, 55(2): 153-156.
[14]	郭静杨景煜丁黎刘明明侯晶梅蒲小霞孙嘉昱李向花. 长脉宽1 064 nm Nd：YAG激光联合含滇山茶和三七等提取物的外用乳剂治疗黄褐斑的疗效[J]. 中华皮肤科杂志, 2022, 55(1): 61-64.
[15]	王媛余美文向睿宇李锁李志量荆可张寒梅冯素英. 盐裂皮肤-间接免疫荧光方法优化及在大疱性类天疱疮抗体检测中的应用[J]. 中华皮肤科杂志, 2022, 55(1): 12-15.

接触性荨麻疹诊治进展

Diagnosis and treatment of contact urticaria

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 39

相关文章 15

Metrics

本文评价

推荐阅读 10